Начало・Списък с акции・Vaxcyte Inc

Vaxcyte Inc

Отворен

СекторЗдравеопазване

57.9 -3.53

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

56.95

Максимум

60.14

Ключови измерители
By Trading Economics
Приходи	-284M -605M
EPS	-1.97
Служители	507
EBITDA	22M -292M

Препоръки
By TipRanks
Препоръки	Силна покупка
12-месечна прогноза	+94.24% upside

Дивиденти
By Acuity
Следващи печалби	2.11.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	944M 8.7B
Предишно отваряне	61.43
Предишно затваряне	57.9

Настроения в новините

By Acuity

50%

171 / 340 Класиране в Healthcare

Vaxcyte Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

12.08.2026 г., 19:46 ч. UTC

Vaxcyte Inc shares are higher today, supported by broader market gains following positive sentiment from the recent inflation report. The stock remains above its 20-day moving average.

11.08.2026 г., 23:11 ч. UTC

Vaxcyte Inc shares are higher in after-market trading, reflecting positive momentum despite no specific news driving the price action.

10.08.2026 г., 19:56 ч. UTC

Vaxcyte Inc shares are higher, continuing gains since Friday's close, reaching a peak earlier in the session. No specific news was identified for the move.

7.08.2026 г., 21:01 ч. UTC

Vaxcyte Inc shares are lower in after-market hours, continuing a weak trading session without any specific news to explain the decline.

6.08.2026 г., 20:03 ч. UTC

News

Vaxcyte reports a net loss of $284.3 million for Q2. Shares are trading higher as the company anticipates key Phase 3 trial data in 2027.

5.08.2026 г., 19:16 ч. UTC

Vaxcyte Inc. shares are higher today, aligning with broader market trends, despite no specific news identified. The stock remains near its one-month range low.

4.08.2026 г., 20:21 ч. UTC

Vaxcyte Inc. shares are lower in after-market trading, remaining flat since Tuesday's close and positioned below its 20-day moving average.

3.08.2026 г., 19:46 ч. UTC

Vaxcyte Inc's shares are lower today, continuing a decline since Friday. The stock is trading near the lower end of its one-month range.

31.07.2026 г., 19:56 ч. UTC

Correlated Moves

Shares lower amid broader sector sentiment; SPDR S&P Biotech ETF declines.

30.07.2026 г., 18:52 ч. UTC

Vaxcyte Inc's shares are higher today amid strong buying activity, reaching an intraday high but remain below the 20-day moving average.

29.07.2026 г., 18:23 ч. UTC

Vaxcyte Inc is lower in Wednesday's session, breaking a trend of higher daily closes. No specific news was identified to explain the decline.

28.07.2026 г., 18:46 ч. UTC

Vaxcyte Inc. shares are trading lower amid broader market trends and volatility, remaining below the 20-day moving average as bond yields decline.

27.07.2026 г., 19:46 ч. UTC

Vaxcyte Inc shares are trading higher today, despite earlier declines and without specific company news. Broader market volatility is influenced by falling crude oil prices.

23.07.2026 г., 19:16 ч. UTC

Vaxcyte Inc shares are lower today amid a broader decline in tech stocks following earnings reports from Alphabet and Tesla. No specific news was identified.

21.07.2026 г., 18:26 ч. UTC

Vaxcyte Inc is trading higher today, continuing its advance since Monday's close. This movement occurs despite concerns over rising treasury yields and geopolitical tensions.

Сравнение с други в отрасъла

Ценова промяна

Vaxcyte Inc Прогноза

Ценова цел

By TipRanks

94.24% нагоре

12-месечна прогноза

Среден 114.33 USD 94.24%

Висок 163 USD

Нисък 75 USD

Според 7 анализатори от Wall Street, предложили 12-месечна ценова цел за Vaxcyte Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Силна покупка

7 ratings

Купи

Задържане

Продай

Според 7 анализатори, дали борсови рейтинги на Vaxcyte Inc през последните 3 месеца.

Настроение

By Acuity

171 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Vaxcyte Inc

Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine for the prevention of invasive pneumococcal disease. The company also develops VAX-31 to protect against emerging strains and to help address antibiotic resistance; VAX-A1, a novel conjugate vaccine candidate to prevent disease caused by Group A Streptococcus; VAX-PG, a novel protein vaccine candidate targeting keystone pathogen responsible for periodontitis; and VAX-GI to prevent Shigella, a bacterial illness. The company was formerly known as SutroVax, Inc. and changed its name to Vaxcyte, Inc. in May 2020. Vaxcyte, Inc. was incorporated in 2013 and is headquartered in San Carlos, California.